Browsing Research publications by Subject "Small cell lung cancer: Nivolumab"
Now showing items 1-1 of 1
-
(Journal of Thoracic Oncology, 2020-03)Introduction: Nivolumab monotherapy is approved in the United States for third-line or later metastatic small cell lung cancer based on pooled data from nonrandomized and randomized cohorts of the multicenter, open-label, ...